Clinical evolution

Icon eyeing China

Icon eyeing China

By Nick Taylor

Icon is looking to expand its bioanalytical capacity in Asia, notably in China, and bolster its genomics, proteomics and cell-based assay capabilities, according to a VP who discussed diversification of the business.

Follow us

Products

View more

Webinars